Evidence map›Paper›PMID 33389155›Full record

ArticleMikrochimica acta2021

Hybrid MoS

Yuanxia Lv, Xiaohuan Qin, Kun Hu, Yong Huang, Shulin Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yuanxia LvState Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, People's Republic of China.
Xiaohuan QinState Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, People's Republic of China.
Kun HuState Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, People's Republic of China. hukun216@163.com.ORCID 0000-0003-4420-2467
Yong HuangState Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, People's Republic of China.
Shulin ZhaoState Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, People's Republic of China.
Guangxi Normal University · CN

Funding

National Natural Science Foundation of China 21565007National Natural Science Foundation of China 22064002Natural Science Foundation of Guangxi Province 2020GXNSFAA238038
6 · The paper itself

Abstract

A novel matrix-assisted laser desorption/ionization time-of-flight mass spectrometric method (MALDI-TOF MS) for determination of highly sensitive small molecular compounds was developed based on molybdenum disulfide nanosheets hybridized with ultrathin graphitic carbon nitride (MoS

Indexed as

Amino AcidsAnti-Bacterial AgentsCyclodextrinsDisulfidesGraphiteHumansLimit of DetectionMass SpectrometryMolybdenumNanostructuresNitrogen CompoundsPolyethylene GlycolsReproducibility of ResultsUric AcidAmino AcidsAnti-Bacterial AgentsCyclodextrinsDisulfidesGraphitegraphitic carbon nitrideMolybdenummolybdenum disulfideNitrogen CompoundsPolyethylene GlycolsUric AcidComplex matrix analysisMatrix-assisted laser desorption/ionization time-of-flight mass spectrometryMoS2/g-C3N4Small molecule determination

Identifiers

PMID33389155
OpenAlexW3119175846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.